2026 Q1 -tulosraportti
66 päivää sitten
‧1 t 2 min
7,95 DKK/osake
Viimeisin osinko
3,65%Tuotto/v
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 5.8. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 6.5. | ||
Vuosittainen yhtiökokous 2026 26.3. | ||
2025 Q4 -tulosraportti 4.2. | ||
Ylimääräinen yhtiökokous 2025 14.11.2025 | ||
2025 Q3 -tulosraportti 5.11.2025 |
Asiakkaat katsoivat myös
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
·5 t sittenA bit of a clarification of what I've written about before, but I can't help myself: If we look at the P/E ratio in relation to expected growth (the PEG ratio), LLY and NVO have an average value of 2.59. With this ratio for both companies, it means that one expects a growth of approx. 16% and 4.5% respectively, seen over a 5-year period. Thus, still a growth for LLY that is approx. 4 times greater compared to NVO. If one looks at the sensitivity, let's say ÷3% for LLY and +3% for NVO and the same PEG = 2.59, it gives the following pricing, all else being equal: NVO P/E = 19.7 and share price = 530 kr. (+65%). LLY P/E = 34.5 and share price = 970 $ (÷18%). It clearly shows how sensitive NVO is. Just 3% higher growth for NVO gives +65% on the share price. LLY is less sensitive, ÷3% gives 'only' ÷18% on the share price.
6 t sittenUSA💸💸💸
Will rise in fits and starts towards August 5th. The majority expects yet another upward adjustment of guidance, so FOMO will prevail. Guess the price will be at 335-340 on August 4th.
·9 t sittenIf you factor in inflation, the Novo share is actually cheaper than 5 years ago, that is, before the whole Ozempic adventure. Is Novo better off now than it was then? Yes, by far. Does the share price make any sense then? No, and it doesn't have to. We live in a time where the only thing that counts is hype and vibes, and where "boring" and rock-solid stable shares like Novo are out, and therefore have a far too low price in relation to their profits. Elon Musk's companies together had a deficit of approx. 900 million dollars last year, where he both stood and gave Nazi salutes, was revealed in the Epstein files and where it was very clear that the Chinese make better and cheaper cars than Tesla. Now he is the richest man in the world. Again, it doesn't have to make sense. The market and investors have been drinking retardo-juice for some years now, especially regarding AI, and they are still guzzling it down at full throttle. But it will end one day, when people realize that the emperor has no clothes, and then the large solid companies with large solid profits will become popular again, because they are a safe haven. Novo sells neither hype nor crappy robots like Optimus, which are 5 years behind the Chinese, they sell medicine, and that will always be needed. See your Novo shares as a vintage port wine. Buy it, throw it in the cellar and let it sit for 15-20 years or more. Then it will be really good!
For 5 years (and long before that) it was well known that the weight loss adventure was on its way. Novo has been developing it since the early 00s. Stocks are priced based on future expectations. Therefore, it makes perfect sense that it was more expensive at that time. If NOVO had something just as big in the pipeline tomorrow, you would also see it reflected in the share price. But what do they actually have? They have pretty much handed over the weight loss adventure to the competitors. Don't get me wrong, it's a good enough stock, priced realistically. They have a stable income and pay dividends. And it's a good enough counterbalance to, for example, tech stocks in the portfolio. I'm not saying one shouldn't buy it - I own it myself But there's no reason for the share price to be higher than it is today. Then NOVO must come out with higher expectations for the bottom line if that is to change.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2026 Q1 -tulosraportti
66 päivää sitten
‧1 t 2 min
7,95 DKK/osake
Viimeisin osinko
3,65%Tuotto/v
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·5 t sittenA bit of a clarification of what I've written about before, but I can't help myself: If we look at the P/E ratio in relation to expected growth (the PEG ratio), LLY and NVO have an average value of 2.59. With this ratio for both companies, it means that one expects a growth of approx. 16% and 4.5% respectively, seen over a 5-year period. Thus, still a growth for LLY that is approx. 4 times greater compared to NVO. If one looks at the sensitivity, let's say ÷3% for LLY and +3% for NVO and the same PEG = 2.59, it gives the following pricing, all else being equal: NVO P/E = 19.7 and share price = 530 kr. (+65%). LLY P/E = 34.5 and share price = 970 $ (÷18%). It clearly shows how sensitive NVO is. Just 3% higher growth for NVO gives +65% on the share price. LLY is less sensitive, ÷3% gives 'only' ÷18% on the share price.
- 6 t sittenUSA💸💸💸Will rise in fits and starts towards August 5th. The majority expects yet another upward adjustment of guidance, so FOMO will prevail. Guess the price will be at 335-340 on August 4th.
- ·9 t sittenIf you factor in inflation, the Novo share is actually cheaper than 5 years ago, that is, before the whole Ozempic adventure. Is Novo better off now than it was then? Yes, by far. Does the share price make any sense then? No, and it doesn't have to. We live in a time where the only thing that counts is hype and vibes, and where "boring" and rock-solid stable shares like Novo are out, and therefore have a far too low price in relation to their profits. Elon Musk's companies together had a deficit of approx. 900 million dollars last year, where he both stood and gave Nazi salutes, was revealed in the Epstein files and where it was very clear that the Chinese make better and cheaper cars than Tesla. Now he is the richest man in the world. Again, it doesn't have to make sense. The market and investors have been drinking retardo-juice for some years now, especially regarding AI, and they are still guzzling it down at full throttle. But it will end one day, when people realize that the emperor has no clothes, and then the large solid companies with large solid profits will become popular again, because they are a safe haven. Novo sells neither hype nor crappy robots like Optimus, which are 5 years behind the Chinese, they sell medicine, and that will always be needed. See your Novo shares as a vintage port wine. Buy it, throw it in the cellar and let it sit for 15-20 years or more. Then it will be really good!For 5 years (and long before that) it was well known that the weight loss adventure was on its way. Novo has been developing it since the early 00s. Stocks are priced based on future expectations. Therefore, it makes perfect sense that it was more expensive at that time. If NOVO had something just as big in the pipeline tomorrow, you would also see it reflected in the share price. But what do they actually have? They have pretty much handed over the weight loss adventure to the competitors. Don't get me wrong, it's a good enough stock, priced realistically. They have a stable income and pay dividends. And it's a good enough counterbalance to, for example, tech stocks in the portfolio. I'm not saying one shouldn't buy it - I own it myself But there's no reason for the share price to be higher than it is today. Then NOVO must come out with higher expectations for the bottom line if that is to change.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 5.8. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 6.5. | ||
Vuosittainen yhtiökokous 2026 26.3. | ||
2025 Q4 -tulosraportti 4.2. | ||
Ylimääräinen yhtiökokous 2025 14.11.2025 | ||
2025 Q3 -tulosraportti 5.11.2025 |
2026 Q1 -tulosraportti
66 päivää sitten
‧1 t 2 min
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 5.8. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 6.5. | ||
Vuosittainen yhtiökokous 2026 26.3. | ||
2025 Q4 -tulosraportti 4.2. | ||
Ylimääräinen yhtiökokous 2025 14.11.2025 | ||
2025 Q3 -tulosraportti 5.11.2025 |
7,95 DKK/osake
Viimeisin osinko
3,65%Tuotto/v
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·5 t sittenA bit of a clarification of what I've written about before, but I can't help myself: If we look at the P/E ratio in relation to expected growth (the PEG ratio), LLY and NVO have an average value of 2.59. With this ratio for both companies, it means that one expects a growth of approx. 16% and 4.5% respectively, seen over a 5-year period. Thus, still a growth for LLY that is approx. 4 times greater compared to NVO. If one looks at the sensitivity, let's say ÷3% for LLY and +3% for NVO and the same PEG = 2.59, it gives the following pricing, all else being equal: NVO P/E = 19.7 and share price = 530 kr. (+65%). LLY P/E = 34.5 and share price = 970 $ (÷18%). It clearly shows how sensitive NVO is. Just 3% higher growth for NVO gives +65% on the share price. LLY is less sensitive, ÷3% gives 'only' ÷18% on the share price.
- 6 t sittenUSA💸💸💸Will rise in fits and starts towards August 5th. The majority expects yet another upward adjustment of guidance, so FOMO will prevail. Guess the price will be at 335-340 on August 4th.
- ·9 t sittenIf you factor in inflation, the Novo share is actually cheaper than 5 years ago, that is, before the whole Ozempic adventure. Is Novo better off now than it was then? Yes, by far. Does the share price make any sense then? No, and it doesn't have to. We live in a time where the only thing that counts is hype and vibes, and where "boring" and rock-solid stable shares like Novo are out, and therefore have a far too low price in relation to their profits. Elon Musk's companies together had a deficit of approx. 900 million dollars last year, where he both stood and gave Nazi salutes, was revealed in the Epstein files and where it was very clear that the Chinese make better and cheaper cars than Tesla. Now he is the richest man in the world. Again, it doesn't have to make sense. The market and investors have been drinking retardo-juice for some years now, especially regarding AI, and they are still guzzling it down at full throttle. But it will end one day, when people realize that the emperor has no clothes, and then the large solid companies with large solid profits will become popular again, because they are a safe haven. Novo sells neither hype nor crappy robots like Optimus, which are 5 years behind the Chinese, they sell medicine, and that will always be needed. See your Novo shares as a vintage port wine. Buy it, throw it in the cellar and let it sit for 15-20 years or more. Then it will be really good!For 5 years (and long before that) it was well known that the weight loss adventure was on its way. Novo has been developing it since the early 00s. Stocks are priced based on future expectations. Therefore, it makes perfect sense that it was more expensive at that time. If NOVO had something just as big in the pipeline tomorrow, you would also see it reflected in the share price. But what do they actually have? They have pretty much handed over the weight loss adventure to the competitors. Don't get me wrong, it's a good enough stock, priced realistically. They have a stable income and pay dividends. And it's a good enough counterbalance to, for example, tech stocks in the portfolio. I'm not saying one shouldn't buy it - I own it myself But there's no reason for the share price to be higher than it is today. Then NOVO must come out with higher expectations for the bottom line if that is to change.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt